MRI- and ultrasound-guided freezing treatment for low-risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests using MRI and ultrasound together to guide freezing (cryoablation) treatment for prostate cancer. It may help target the tumor more precisely while avoiding areas that could cause side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 55–65, or if you’re over 65, you have low or intermediate prostate cancer
- Your biopsy shows less than 50% of sampled cores are cancerous in each prostate side (lobe)
- Your scans/biopsy do not show spread outside the prostate, into the seminal vesicles, or anywhere else in the body
- You must have had an MRI of the prostate either before the biopsy or more than 10 weeks after the biopsy
- You are being treated with prostate cryotherapy (freezing of the prostate) guided by MRI-ultrasound matching
- You have not had prostate cancer surgery before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at a treatment that uses MRI and ultrasound to guide a laser to destroy prostate cancer. It may help men with low- or intermediate-risk prostate cancer who do not have spread beyond the prostate.
This trial studies a treatment where doctors use MRI pictures to guide freezing of a prostate tumor. It may help men with smaller, well-placed prostate cancers who cannot or do not want surgery or radiation right now.
This trial is testing whether freezing (cryotherapy) or using high-frequency ultrasound (HIFU) to destroy only the cancer spots in the prostate is safe and effective for men with early-stage prostate cancer. It's a less invasive option that targets just the tumor, not the whole prostate.
This trial tests whether freezing only the cancer area in the prostate (focal cryotherapy) can control intermediate-risk prostate cancer. It aims to limit treatment to one tumor focus while closely checking results with targeted and follow-up testing.
This trial tests a newer way to treat certain low- to intermediate-risk prostate cancers using MRI guidance and an ultrasound probe placed through the urethra. It aims to destroy the tumor while using imaging to help target it more precisely.
This trial tests whether a precisely targeted laser procedure—guided by MRI images—can treat prostate cancer. It may help some men who have a certain type and location of tumor while aiming to avoid nearby sensitive structures.
Hear when a new Neoplasms Prostate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.